These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


501 related items for PubMed ID: 29787487

  • 1. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M, Chan EW, Omar A.
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [Abstract] [Full Text] [Related]

  • 2. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF, Melles RB.
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [Abstract] [Full Text] [Related]

  • 3. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF, Hu J.
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [Abstract] [Full Text] [Related]

  • 4. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV, Krema H, Hammoudi DS, Lipton JH, Simpson ER, Boyd S, Easterbrook M.
    Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
    [Abstract] [Full Text] [Related]

  • 5. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
    Chew AL, Sampson DM, Chelva E, Khan JC, Chen FK.
    Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
    [Abstract] [Full Text] [Related]

  • 6. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA.
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [Abstract] [Full Text] [Related]

  • 7. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M, Stover NB, Francis PJ, Weleber RG.
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [Abstract] [Full Text] [Related]

  • 8. Optical coherence tomography in a patient with chloroquine-induced maculopathy.
    Korah S, Kuriakose T.
    Indian J Ophthalmol; 2008 Jan; 56(6):511-3. PubMed ID: 18974527
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Night Blindness, Ring Scotoma, and a Nonrecordable Electroretinogram in an Elderly Woman.
    Grassi MA, Maker MP, Marmor MF.
    JAMA Ophthalmol; 2019 Jan 01; 137(1):109-110. PubMed ID: 30452517
    [No Abstract] [Full Text] [Related]

  • 11. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of Ophthalmology.
    Ophthalmology; 2011 Feb 01; 118(2):415-22. PubMed ID: 21292109
    [Abstract] [Full Text] [Related]

  • 12. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS, Neal JW, Wakelee HA, Sequist LV, Marmor MF.
    Am J Ophthalmol; 2015 Oct 01; 160(4):799-805.e1. PubMed ID: 26189086
    [Abstract] [Full Text] [Related]

  • 13. Hydroxychloroquine retinopathy after short-term therapy.
    Phillips BN, Chun DW.
    Retin Cases Brief Rep; 2014 Oct 01; 8(1):67-9. PubMed ID: 25372212
    [Abstract] [Full Text] [Related]

  • 14. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC, Ahmadi S, Hamilton J, Gao J, Virgili G, Coupland SG, Gottlieb CC.
    Am J Ophthalmol; 2019 Oct 01; 206():132-139. PubMed ID: 31078540
    [Abstract] [Full Text] [Related]

  • 15. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM, Chen KG, Alvarez JA, Wong WT, Chew EY, Cukras CA.
    Retina; 2019 Mar 01; 39(3):473-484. PubMed ID: 30741731
    [Abstract] [Full Text] [Related]

  • 16. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB, Marmor MF.
    JAMA Ophthalmol; 2014 Dec 01; 132(12):1453-60. PubMed ID: 25275721
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.
    Marmor MF, Chien FY, Johnson MW.
    JAMA Ophthalmol; 2013 Apr 01; 131(4):476-80. PubMed ID: 23710501
    [Abstract] [Full Text] [Related]

  • 19. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK, Yu M, Weleber RG.
    Arch Ophthalmol; 2004 Jul 01; 122(7):973-81. PubMed ID: 15249360
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.